RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice

Published:2015-10-19 Issue:2 Volume:76 Page:184-198
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Zhao Zhigang¹,He Jun¹,Kang Ran¹,Zhao Shankun¹,Liu Luhao¹,Li Futian¹

Affiliation:

1. Department of Urology and Andrology; The First Affiliated Hospital of Guangzhou Medical University; Guangzhou Guangdong Province China

Funder

National Natural Science Foundation of China

Yangcheng Scholar Project of Guangzhou Education Bureau, China

Publisher

Wiley

Subject

Urology,Oncology

Reference30 articles.

1. Cancer statistics, 2014;Rebecca Siegel;CA Cancer J Clin,2014

2. Carcinoma of the prostate;Gittes;N Engl J Med,1991

3. Prostate cancer;Damber;Lancet,2008

4. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer;Reiter;Proc Natl Acad Sci USA,1998

5. Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer;Gu;Oncogene,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mediator kinase inhibition reverses castration resistance of advanced prostate cancer;Journal of Clinical Investigation;2024-03-28

2. Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers;Journal of Clinical Investigation;2024-03-26

3. CDK19 and CDK8 Mediator kinases drive androgen-independentin vivogrowth of castration-resistant prostate cancer;2023-08-11

4. The role of GPLD1 in chronic diseases;Journal of Cellular Physiology;2023-07

5. RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics;Frontiers in Nanotechnology;2021-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3